-
Mashup Score: 4
ASCO 2023, bladder cancer, Anti-Tumor Activity of Intravesical Instillation of TARA-002, lyophilized biological preparation for instillation, TARA-002, ADVANCED-2 study, non muscle invasive bladder cancer (NMIBC), dose regulation for bladder cancer treatment.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Log into Facebook | Facebook - 2 year(s) ago
Log into Facebook to start sharing and connecting with your friends, family, and people you know.
Source: FacebookCategories: Hem/Oncs, Latest HeadlinesTweet-
Grateful to @rschilsky @ASCO for #TAPUR study offering encouraging #molecularly 🎯Tx to patients living with #advanced #cancer. @SylvesterCancer is home for #TAPUR in #SoFl #BreastCancerAwarenessMonth #mbc https://t.co/T9SlFvgmFy
-
-
Mashup Score: 1ESMO Virtual Advanced Course on NTRK 2022 - 2 year(s) ago
Virtual, 5-6 December 2022
Source: www.esmo.orgCategories: Latest Headlines, Oncologists2Tweet-
Happy to share my #co_chair Dr. @DrHongchengZhu's introductory message in #Mandarin to the upcoming @myESMO #virtual #advanced course on #NTRKpositive cancers to be held on 5-6 December 2022. Deadline for application is <11 days away! Apply online at https://t.co/5ZSa9M7FSe https://t.co/0Uuaf4p9Ps
-
-
Mashup Score: 0ESMO Virtual Advanced Course on NTRK 2022 - 2 year(s) ago
Virtual, 5-6 December 2022
Source: www.esmo.orgCategories: Latest Headlines, Oncologists2Tweet-
📢📢📢 #FinalCall to #oncology #trainees & seasoned colleagues to join us at @myESMO #virtual #advanced course on #NTRK+ disease: 5-6 Dec! Free to eligible @myesmo members. Promise to be #educational & #interactive experience. Apply here: https://t.co/5ZSa9M7FSe @DrHongchengZhu https://t.co/ObyVoahyUx https://t.co/L1ckBT6DIs
-
-
Mashup Score: 2
PPPY rates were typically lower with FF/UMEC/VI versus FF/VI or UMEC/VI.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet-
#Single- #Inhaler #Triple #Therapy in #Patients with #Advanced #COPD: #Bayesian #Modeling of the #Healthcare #Resource #Utilization Data and Associated Costs from the IMPACT Trial #Pulmonary #Lung https://t.co/gro40z3T5G https://t.co/BZkl9XtBtH
-
-
Mashup Score: 0
Article InfoPublication HistoryAccepted: July 13, 2022Received in revised form: June 28, 2022Received: March 24, 2022Publication stageIn Press Journal Pre-ProofFootnotesConflict of interest disclosures:KH has received research funding from Thermo Fisher and consultancy or lecture fees from Allergopharma, ALK-Abello,…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! Presence of #neoplastic #mast #cells in #ascites in #advanced #systemic #mastocytosis https://t.co/feQPCUstXa
-
-
Mashup Score: 19The Next Generation - 2 year(s) ago
Interest is waning in advanced heart failure and transplant cardiology subspecialty training. According to the National Resident Matching Program, since the first match cycle for advanced heart failure and transplant cardiology (AHFTC) fellowships in 2020, the number of applicants has declined in each of the subsequent two years.1 Since 2020, the number decreased from 84 to 80 (2021) to 72 (2022)…
Source: Journal of Cardiac FailureCategories: Expert Picks, Latest HeadlinesTweet-
RT @MarkDrazner: My July @HFSA President's Message in @JCardFail. https://t.co/xGb1oCKvZT Declining number of applicants for #Advanced #Hea…
-
-
Mashup Score: 17The Next Generation - 2 year(s) ago
Interest is waning in advanced heart failure and transplant cardiology subspecialty training. According to the National Resident Matching Program, since the first match cycle for advanced heart failure and transplant cardiology (AHFTC) fellowships in 2020, the number of applicants has declined in each of the subsequent two years.1 Since 2020, the number decreased from 84 to 80 (2021) to 72 (2022)…
Source: Journal of Cardiac FailureCategories: Cardiology News and Journals, Latest HeadlinesTweet-
RT @MarkDrazner: My July @HFSA President's Message in @JCardFail. https://t.co/xGb1oCKvZT Declining number of applicants for #Advanced #Hea…
-
-
Mashup Score: 15The Next Generation - 2 year(s) ago
Interest is waning in advanced heart failure and transplant cardiology subspecialty training. According to the National Resident Matching Program, since the first match cycle for advanced heart failure and transplant cardiology (AHFTC) fellowships in 2020, the number of applicants has declined in each of the subsequent two years.1 Since 2020, the number decreased from 84 to 80 (2021) to 72 (2022)…
Source: Journal of Cardiac FailureCategories: Cardiologists, Latest HeadlinesTweet-
RT @MarkDrazner: My July @HFSA President's Message in @JCardFail. https://t.co/xGb1oCKvZT Declining number of applicants for #Advanced #Hea…
-
-
Mashup Score: 0Frontline TTX-030 Plus Budigalimab/mFOLFOX6 Is Safe, Tolerable in Advanced Gastric/GEJ Cancer - 2 year(s) ago
TTX-030 is the first fully human IgG4 antibody designed to target CD39, as well as the first CD39 inhibitor to undergo a phase 1 clinical trial.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
RT @Rndubois: Frontline #TTX_030 Plus Budigalimab/mFOLFOX6 Is Safe, Tolerable in #Advanced #Gastric/GEJ #Cancer: https://t.co/6SVLJt6GTL v…
-
#ADVANCED-2: phase 1b/2 dose expansion, open-label study to evaluate safety and anti-tumor activity of intravesical instillation of TARA-002 in adults with high-grade #NMIBC. Presented by Wei Sun, MD. #ASCO23 coverage by @zklaassen_md @GACancerCenter > https://t.co/zNTeEnonTa https://t.co/JUBDqJj6RZ